- MedChemExpress: Master of Bioactive Molecules | Inhibitors, Screening . . .
MedChemExpress (MCE) provides 50,000+ selective Inhibitors and Recombinant Proteins with high purity and quality Cited in 30,000+ publications by worldwide scientists
- Contact Us - MedChemExpress
customer service E-mail: Sales@MedChemExpress com Tel: 609-228-6898 Tech-Support: tech@medchemexpress com Address: 1 Deer Park Dr, Suite F, Monmouth Junction, NJ 08852, USA
- Compound Library for HTS - Drug Discovery | MedChemExpress
MedChemExpress (MCE) ready-to-use compound libraries consist of over 20,000 small molecules with validated biological and pharmacological activities Optimized for drug discovery and new indication research They are available for high-throughput screening (HTS) and high-content screening (HCS)
- About Us - MedChemExpress
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use
- Recombinant Proteins | Superior Biological Activity | MedChemExpress
MedChemExpress (MCE) offers a comprehensive collection of recombinant proteins with excellent lot-to-lot consistency, superior activity and low endotoxin level MedChemExpress (MCE) recombinant proteins include: cytokines, enzymes, growth factors, hormones, receptors, transcription factors, antibody fragments, etc
- All Products | MedChemExpress
50,000+ Inhibitors, Proteins 200+ Compound Libraries High-purity quality life science Kits, Dyes and Antibodies Targeting 1,000+ proteins One-Stop ADC and PROTAC customized service
- T0901317 | LXR Agonist | MedChemExpress
T0901317 is an orally active and highly selective LXR agonist with an EC50 of 20 nM for LXRα T0901317 activates FXR with an EC50 of 5 μM T0901317 is RORα and RORγ dual inverse agonist with Ki values of 132 nM and 51 nM, respectively T0901317 induces apoptosis and inhibits the development of atherosclerosis in low-density lipoprotein (LDL) receptor-deficient mice - Mechanism of Action
- STM2457 | METTL3 Inhibitor | MedChemExpress
STM2457 is a first-in-class, highly potent, selective and orally active METTL3 inhibitor with an IC50 of 16 9 nM STM2457 can be used for the research of acute myeloid leukaemia (AML) - Mechanism of Action Protocol
|